PKM2 released by neutrophils at wound site facilitates early wound healing by promoting angiogenesis

Wound Repair and Regeneration

Volumn 24, Issue 2, 2016, Pages 328-336

  Zhang, Yinwei ^a   Li, Liangwei ^a   Liu, Yuan ^a   Liu, Zhi Ren ^a  

^a GEORGIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS MODULATOR; RECOMBINANT ENZYME; RECOMBINANT PYRUVATE KINASE M2; UNCLASSIFIED DRUG; WOUND HEALING PROMOTING AGENT; PYRUVATE KINASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME RELEASE; EXTRACELLULAR SPACE; FIBROBLAST; IMMUNOHISTOCHEMISTRY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; SKIN INJURY; TOPICAL TREATMENT; WOUND HEALING; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; DISEASE MODEL; ENZYMOLOGY; EXTRACELLULAR MATRIX; INFLAMMATION; INJURY; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; SECRETION (PROCESS);

ANIMALS; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; EXTRACELLULAR MATRIX; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; NEUTROPHILS; PYRUVATE KINASE; WOUND HEALING; WOUNDS AND INJURIES;

EID: 84960384278     PISSN: 10671927     EISSN: 1524475X     Source Type: Journal    
DOI: 10.1111/wrr.12411     Document Type: Article

References (43)

1. Singer AJ, Clark RA., Cutaneous wound healing. N Engl J Med 1999; 341 (10): 738-46.
2. Diegelmann RF, Evans MC., Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci 2004; 9: 283-9.
3. Broughton G, 2nd, Janis JE, Attinger CE., Wound healing: an overview. Plast Reconstr Surg 2006; 117 (7 Suppl):1e-S-32e-S.
4. Gillitzer R, Goebeler M., Chemokines in cutaneous wound healing. J Leukoc Biol 2001; 69 (4): 513-21.
5. Artlett CM., Inflammasomes in wound healing and fibrosis. J Pathol 2013; 229 (2): 157-67.
6. Dovi JV, He LK, DiPietro LA., Accelerated wound closure in neutrophil-depleted mice. J Leukoc Biol 2003; 73 (4): 448-55.
7. Nishio N, Okawa Y, Sakurai H, Isobe, K., Neutrophil depletion delays wound repair in aged mice. Age (Dordr) 2008; 30 (1): 11-9.
8. Brubaker AL, Schneider DF, Kovacs EJ., Neutrophils and natural killer T cells as negative regulators of wound healing. Exp Rev Dermatol 2011; 6 (1): 5-8.
9. Simpson DM, Ross R., The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J Clin Invest 1972; 51 (8): 2009-23.
10. Gong Y, Koh DR., Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res 2010; 339 (2): 437-48.
11. Hubner G, Werner S., Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp Cell Res 1996; 228 (1): 106-13.
12. Elbers JR, van Unnik JA, Rijksen, G, van Oirschot BA, Roholl PJ, Oosting J, et al., Pyruvate kinase activity and isozyme composition in normal fibrous tissue and fibroblastic proliferations. Cancer 1991; 67 (10): 2552-9.
13. Hacker HJ, Steinberg P, Bannasch,. Pyruvate kinase isoenzyme shift from L-type to M2-type is a late event in hepatocarcinogenesis induced in rats by a choline-deficient/DL-ethionine-supplemented diet. Carcinogenesis 1998; 19 (1): 99-107.
14. Dombrauckas JD, Santarsiero BD, Mesecar AD., Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis. Biochemistry 2005; 44 (27): 9417-29.
15. Gao X, Wang H, Yang JJ, Liu X, Liu ZR., Pyruvate kinase m2 regulates gene transcription by acting as a protein kinase. Mol Cell 2012; 45 (5): 598-609.
16. Luo W, Hu H, Chang R, Zhong J, Knabel M, O'Meally R, et al., Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 2011; 145 (5): 732-44.
17. Yang W, Xia Y, Ji H, Zheng Y, Liang J, Huang W, et al., Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 2011; 480 (7375): 118-22.
18. Schneider J., Tumor markers in detection of lung cancer. Adv Clin Chem 2006; 42: 1-41.
19. Ugurel S, Bell N, Sucker A, Zimpfer A, Rittgen W, Schadendorf D., Tumor type M2 pyruvate kinase (TuM2-PK) as a novel plasma tumor marker in melanoma. Int J Cancer 2005; 117 (5): 825-30.
20. Weinberger R, Appel B, Stein A, Metz Y, Neheman A, Barak M., The pyruvate kinase isoenzyme M2 (Tu M2-PK) as a tumour marker for renal cell carcinoma. Eur J Cancer Care (Engl) 2007; 16 (4): 333-7.
21. Li L, Zhang Y, Qiao J, Yang JJ, Liu ZR., Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis. J Biol Chem 2014; 289: 25812-21.
22. Jeffery J, Lewis SJ, Ayling RM., Fecal dimeric M2-pyruvate kinase (tumor M2-PK) in the differential diagnosis of functional and organic bowel disorders. Inflamm Bowel Dis 2009; 15 (11): 1630-4.
23. Staib P, Hoffmann M, Schinkothe T., Plasma levels of tumor M2-pyruvate kinase should not be used as a tumor marker for hematological malignancies and solid tumors. Clin Chem Lab Med 2006; 44 (1): 28-31.
24. Hathurusinghe HR, Goonetilleke KS, Siriwardena AK., Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy. Ann Surg Oncol 2007; 14 (10): 2714-20.
25. Gao X, Wang H, Yang JJ, Chen J, Jie J, Li L, et al., Reciprocal regulation of protein kinase and pyruvate kinase activities of pyruvate kinase m2 by growth signals. J Biol Chem 2013; 288 (22): 15971-9.
26. Li L, Zhang Y, Qiao J, Yang JJ, Liu ZR., Pyruvate kinase M2 in blood circulation facilitates tumor growth by promoting angiogenesis. J Biol Chem 2014; 289 (37): 25812-21.
27. Tonnesen MG, Feng X, Clark RA., Angiogenesis in wound healing. J Investig Dermatol Symp Proc 2000; 5 (1): 40-6.
28. Lominadze G, Powell DW, Luerman GC, Link AJ, Ward RA, McLeish KR., Proteomic analysis of human neutrophil granules. Mol Cell Proteomics 2005; 4 (10): 1503-21.
29. Etiemble J, Boivin P., Pyruvate kinase isozymes among human organs and blood cells. Enzyme 1976; 21 (4): 296-303.
30. Chen CX, Soto I, Guo YL, Liu Y., Control of secondary granule release in neutrophils by Ral GTPase. J Biol Chem 2011; 286 (13): 11724-33.
31. Zen K, Guo YL, Li LM, Bian Z, Zhang CY, Liu Y., Cleavage of the CD11b extracellular domain by the leukocyte serprocidins is critical for neutrophil detachment during chemotaxis. Blood 2011; 117 (18): 4885-94.
32. Takeuchi K, Wood H, Swank RT., Lysosomal elastase and cathepsin G in beige mice. Neutrophils of beige (Chediak-Higashi) mice selectively lack lysosomal elastase and cathepsin G. J Exp Med 1986; 163 (3): 665-77.
33. Takeuchi KH, Swank RT., Inhibitors of elastase and cathepsin G in Chediak-Higashi (beige) neutrophils. J Biol Chem 1989; 264 (13): 7431-6.
34. Gardi C, Cavarra E, Calzoni P, Marcolongo P, de Santi M, Martorana PA, et al., Neutrophil lysosomal dysfunctions in mutant C57 Bl/6J mice: interstrain variations in content of lysosomal elastase, cathepsin G and their inhibitors. Biochem J 1994; 299 (Pt 1): 237-45.
35. Pettipher R, Edwards J, Cruwys S, Jessup E, Beesley J, Henderson B., Pathogenesis of antigen-induced arthritis in mice deficient in neutrophil elastase and cathepsin G. Am J Pathol 1990; 137 (5): 1077-82.
36. Ma Y, Yabluchanskiy A, Lindsey ML., Neutrophil roles in left ventricular remodeling following myocardial infarction. Fibrogenesis Tissue Repair 2013; 6 (1): 11.
37. Mori R, Shaw TJ, Martin P., Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 2008; 205 (1): 43-51.
38. Dahlgren C, Karlsson A, Sendo F., Neutrophil secretory vesicles are the intracellular reservoir for GPI-80, a protein with adhesion-regulating potential. J Leukoc Biol 2001; 69 (1): 57-62.
39. Faurschou M, Borregaard N., Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 2003; 5 (14): 1317-27.
40. Pham CT., Neutrophil serine proteases: specific regulators of inflammation. Nat Rev Immunol 2006; 6 (7): 541-50.
41. Tecchio C, Micheletti A, Cassatella MA., Neutrophil-derived cytokines: facts beyond expression. Front Immunol 2014; 5: 508.
42. Ahmed AS, Dew T, Lawton FG, Papadopoulos AJ, Devaja O, Raju KS, et al., M2-PK as a novel marker in ovarian cancer. A prospective cohort study. Eur J Gynaecol Oncol 2007; 28 (2): 83-8.
43. Schneider J, Neu K, Grimm H, Velcovsky HG, Weisse G, Eigenbrodt E., Tumor M2-pyruvate kinase in lung cancer patients: immunohistochemical detection and disease monitoring. Anticancer Res 2002; 22 (1A): 311-8.